KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer

Oncogene

Volumn 26, Issue 17, 2007, Pages 2525-2534

  Bloch, M ^a   Ousingsawat, J ^b   Simon, R ^a,d   Schraml, P ^a,e   Gasser, T C ^c   Mihatsch, M J ^a   Kunzelmann, K ^b   Bubendorf, L ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Amplifocation; BK channel; KCNMA1; Progression; Prostate cancer

Indexed keywords

ESTRADIOL; IBERIOTOXIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; PROTEIN SUBUNIT; SMALL INTERFERING RNA;

ARTICLE; BENIGN TUMOR; CELL PROLIFERATION; CHROMOSOME 10Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE;

CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 10; GENE AMPLIFICATION; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; PROSTATIC NEOPLASMS;

EID: 34247126153     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210036     Document Type: Article

References (48)

1. Albertson DG, Collins C, McCormick F, Gray JW. (2003). Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
2. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. (2003). Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112: 717-724.
3. Amberg GC, Santana LF. (2003). Downregulation of the BK channel beta1 subunit in genetic hypertension. Circ Res 93: 965-971.
4. Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S. (2002). BKchannel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport 13: 403-407.
5. Bernardino J, Bourgeois CA, Muleris M, Dutrillaux AM, Malfoy B, Dutrillaux B. (1997). Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization. Cancer Genet Cytogenet 96: 123-128.
6. Calderone V. (2002). Large-conductance, Ca(2+)-activated K(+) channels: function, pharmacology and drugs. Curr Med Chem 9: 1385-1395.
7. Christow SP, Bychkov R, Schroeder C, Dietz R, Haller H, Dumler I et al. (1999). Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores. Eur J Biochem 265: 264-272.
8. Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H. (2005). 17-Beta-estradiol activates maxi-Kchannels through a nongenomic pathway in human breast cancer cells. FEBS Lett 579: 2995-3000.
9. Conti M. (2004). Targeting K+ channels for cancer therapy. J Exp Ther Oncol 4: 161-166.
10. Davies AG, Pierce-Shimomura JT, Kim H, VanHoven MK, Thiele TR, Bonci A et al. (2003). A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 115: 655-666.
11. El Gedaily A, Bubendorf L, Willi N, Fu W, Richter J, Moch H et al. (2001). Discovery of new amplification loci in prostate cancer by comparative genomic hybridization. Prostate 46: 184-190.
12. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ et al. (1990). Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265: 11083-11090.
13. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. (1995). Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In vitro Cell Dev Biol Anim 31: 14-24.
14. Helenius MA, Saramaki OR, Linja MJ, Tammela TL, Visakorpi T. (2001). Amplification of urokinase gene in prostate cancer. Cancer Res 61: 5340-5344.
15. Helenius MA, Savinainen KJ, Bova GS, Visakorpi T. (2006). Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors. BJU Int 97: 404-409.
16. Henke G, Maier G, Wallisch S, Boehmer C, Lang F. (2004). Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 199: 194-199.
17. Ho SM. (2004). Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491-503.
18. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L et al. (1980). The LNCaP cell line - a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132.
19. Hsing AW, Tsao L, Devesa SS. (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85: 60-67.
20. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. (1979). Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
21. Kauraniemi P, Barlund M, Monni O, Kallioniemi A. (2001). New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61: 8235-8240.
22. Knuutila S, Autio K, Aalto Y. (2000). Online access to CGH data of DNA sequence copy number changes. Am J Pathol 157: 689.
23. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
24. Koochekpour S, Zhuang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE et al. (2005). Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 44: 351-364.
25. Kunzelmann K, Mall M. (2002). Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82: 245-289.
26. Lau KM, LaSpina M, Long J, Ho SM. (2000). Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175-3182.
27. McCobb DP, Fowler NL, Featherstone T, Lingle CJ, Saito M, Krause JE et al. (1995). A human calcium-activated potassium channel gene expressed in vascular smooth muscle. Am J Physiol 269: H767-H777.
28. O'Grady SM, Lee SY. (2005). Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37: 1578-1594.
29. Olsen ML, Weaver AK, Ritch PS, Sontheimer H. (2005). Modulation of glioma BKchannels via erbB2. J Neurosci Res 81: 179-189.
30. O'Malley D, Harvey J. (2004). Insulin activates native and recombinant large conductance Ca(2+)-activated potassium channels via a mitogen-activated protein kinase-dependent process. Mol Pharmacol 65: 1352-1363.
31. Orio P, Rojas P, Ferreira G, Latorre R. (2002). New disguises for an old channel: MaxiK channel beta-subunits. News Physiol Sci 17: 156-161.
32. Pardo LA. (2004). Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19: 285-292.
33. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S et al. (1999). Oncogenic potential of EAG K(+) channels. EMBOJ 18: 5540-5547.
34. + channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157-164.
35. + channel function. Proc Natl Acad Sci USA 100: 7803-7807.
36. Petrylak DP, Tangen CM, Hussain MH, Lara Jr PN, Jones JA, Taplin ME et al. (2004). Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513-1520.
37. Quirk JC, Reinhart PH. (2001). Identification of a novel tetramerization domain in large conductance K(ca) channels. Neuron 32: 13-23.
38. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. (1997). GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13: 163.
39. Reiter RE, Sato I, Thomas G, Qian J, Gu Z, Watabe T et al. (2000). Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer 27: 95-103.
40. Robitaille R, Charlton MP. (1992). Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci 12: 297-305.
41. Sausbier M, Matos JE, Sausbier U, Beranek G, Arntz C, Neuhuber W et al. (2006). Distal colonic K(+) secretion occurs via BKchannels. J Am Soc Nephrol 17: 1275-1282.
42. + channel isoforms from human brain. Neuron 13: 1315-1330.
43. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI et al. (1999). Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285: 1929-1931.
44. + channel activation. Biochem J 377: 569-578.
45. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J et al. (1992). The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41: 665-669.
46. Wang Z. (2004). Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448: 274-286.
47. Weaver AK, Liu X, Sontheimer H. (2004). Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 78: 224-234.
48. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. (2000). BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 279: C1751-9.